ID

32305

Descripción

Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier https://clinicaltrials.gov/ct2/show/NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains the study conclusion form. It's for all workbooks.

Link

https://clinicaltrials.gov/ct2/show/NCT00466947

Palabras clave

Versiones (2)
  1. 26/10/18 26/10/18 -
  2. 27/10/18 27/10/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

26 de octubre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Vaccination against pneumonia and otitis media, NCT00466947

Inglés

Study conclusion

1 formularios  
  1. StudyEvent: ODM
    1. Study conclusion
Administrative data
Descripción

Administrative data

Alias
UMLS CUI-1
C1320722
Subject number
Descripción

Subject number

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Workbook number
Descripción

Workbook number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2986015
Date of study conclusion
Descripción

Date of study conclusion

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
UMLS CUI [1,3]
C0011008
STUDY CONCLUSION: OCCURRENCE OF SERIOUS ADVERSE EVENT
Descripción

STUDY CONCLUSION: OCCURRENCE OF SERIOUS ADVERSE EVENT

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
UMLS CUI-3
C1519255
Did the subject experience any Serious Adverse Event during the study?
Descripción

Serious Adverse Event during study

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0008972
If Serious Adverse Event during the study occured, please specify total number of SAE's
Descripción

Total number of SAE's

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1519255
STATUS OF TREATMENT BLIND
Descripción

STATUS OF TREATMENT BLIND

Alias
UMLS CUI-1
C0749659
UMLS CUI-2
C2347038
Was the treatment blind broken during the study?
Descripción

Complete Serious Adverse Event report as appropriate. For workbook 2 you can also complete Non-Serious Adverse Event section as appropriate.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0749659
UMLS CUI [1,2]
C2347038
If treatment was blind broken, complete the date
Descripción

Treatment blind broken, date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0749659
UMLS CUI [1,3]
C2347038
Treatment blind broken, reason
Descripción

Treatment blind broken, reason

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0749659
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C0566251
If other reason for treatment blind broken, please specify
Descripción

Other reason for treatment blind broken

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0749659
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C0566251
ELIMINATION CRITERIA
Descripción

ELIMINATION CRITERIA

Alias
UMLS CUI-1
C0680251
Did any elimination criteria become applicable since last visit?
Descripción

Please tick all that applies in following items.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1706839
Chronic administration of immunosuppressants or other immune-modifying drugs.
Descripción

Chronic administration is defined as more than 14 days

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0021081
UMLS CUI [1,3]
C0205191
UMLS CUI [1,4]
C0005525
Major congenital defects or serious chronic illness.
Descripción

Elimination criteria: Major congenital defects/serious chronic illness.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0220810
UMLS CUI [2,2]
C0205164
UMLS CUI [3,1]
C0008679
UMLS CUI [3,2]
C0205404
Any confirmed or suspected immunosuppressive or immunodeficient condition.
Descripción

Elimination criteria: confirmed/suspected immunosuppressive/immunodeficient condition.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0750484
UMLS CUI [2,2]
C3829792
UMLS CUI [3,1]
C0750484
UMLS CUI [3,2]
C4048329
UMLS CUI [4,1]
C0242114
UMLS CUI [4,2]
C3829792
UMLS CUI [5,1]
C0242114
UMLS CUI [5,2]
C4048329
Administration of immunoglobulins and/or any blood derived products.
Descripción

Elimination criteria: immunoglobulins/any blood derived products

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0021027
UMLS CUI [3]
C0456388
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s).
Descripción

Elimination criteria: use of investigational or non-registered product

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0304229
UMLS CUI [2,2]
C0042210
UMLS CUI [2,3]
C1444655
UMLS CUI [2,4]
C2348563
Withdrawing from study
Descripción

Withdrawing from study

Alias
UMLS CUI-1
C0422727
Was the subject withdrawn from the study?
Descripción

If yes, note major reason. Therefore tick one of the following items

Tipo de datos

text

Reason for withdrawal
Descripción

If you tick SAE, please complete and submit SAE report. If you tick AEX, please complete Non-serious Adverse Event section.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0008976
If SAE, please specify SAE Number
Descripción

Please complete and submit SAE report

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0237753
If AEX, please specify AE Number
Descripción

Please complete Non-serious Adverse Event section

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
If AEX, please specify solicited AE Code
Descripción

In workbook 1 and 2 only for immuno and reato subset.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0683368
UMLS CUI [1,2]
C1517001
UMLS CUI [1,3]
C1518404
UMLS CUI [1,4]
C0805701
If protocol violation, please specify
Descripción

Protocol violation

Tipo de datos

text

Alias
UMLS CUI [1]
C1709750
If other reason for withdrawal, please specify
Descripción

Withdrawal, other reason

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C3840932
Who made the decision
Descripción

Dicision made by

Tipo de datos

text

Alias
UMLS CUI [1]
C0679006
Date of last contact
Descripción

Date of last contact

Tipo de datos

date

Alias
UMLS CUI [1]
C0805839
Was the subject in good condition at date of last contact
Descripción

If you tick No, please give details in Adverse Events section.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0805839
UMLS CUI [1,2]
C1142435
INVESTIGATOR'S SIGNATURE
Descripción

INVESTIGATOR'S SIGNATURE

Alias
UMLS CUI-1
C2346576
Investigator's signature
Descripción

Investigator's signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Date of signature
Descripción

Date of signature

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Printed Investigator's name
Descripción

Printed Investigator's name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Volver a la parte superior de la página

Similar models

Study conclusion

1 formularios
  1. StudyEvent: ODM
    1. Study conclusion
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item
Workbook number
integer
C2986015 (UMLS CUI [1])
Workbook number
Code List
Workbook number
CL Item
workbook 1 (1)
CL Item
workbook 2 (2)
CL Item
workbook 3 (3)
Date of study conclusion
Item
Date of study conclusion
date
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item Group
STUDY CONCLUSION: OCCURRENCE OF SERIOUS ADVERSE EVENT
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
Item
Did the subject experience any Serious Adverse Event during the study?
text
C1519255 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Serious Adverse Event during study
Code List
Did the subject experience any Serious Adverse Event during the study?
CL Item
No (N)
CL Item
Yes (Y)
Total number of SAE's
Item
If Serious Adverse Event during the study occured, please specify total number of SAE's
integer
C0449788 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
STATUS OF TREATMENT BLIND
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
Item
Was the treatment blind broken during the study?
text
C0749659 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
Treatment blind broken
Code List
Was the treatment blind broken during the study?
CL Item
No  (N)
CL Item
Yes (Y)
Treatment blind broken, date
Item
If treatment was blind broken, complete the date
date
C0011008 (UMLS CUI [1,1])
C0749659 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,3])
Item
Treatment blind broken, reason
integer
C0749659 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Treatment blind broken, reason
Code List
Treatment blind broken, reason
CL Item
Medical emergency requiring identification of investigational product for further treatments (1)
CL Item
Other (9)
Other reason for treatment blind broken
Item
If other reason for treatment blind broken, please specify
text
C0749659 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Item Group
ELIMINATION CRITERIA
C0680251 (UMLS CUI-1)
Item
Did any elimination criteria become applicable since last visit?
text
C0680251 (UMLS CUI [1,1])
C1706839 (UMLS CUI [1,2])
Elimination criteria become applicable
Code List
Did any elimination criteria become applicable since last visit?
CL Item
No (N)
CL Item
Yes (Y)
Elimination criteria: immunosuppressants/immune-modifying drugs
Item
Chronic administration of immunosuppressants or other immune-modifying drugs.
boolean
C0680251 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0005525 (UMLS CUI [1,4])
Elimination criteria: Major congenital defects/serious chronic illness.
Item
Major congenital defects or serious chronic illness.
boolean
C0680251 (UMLS CUI [1])
C0220810 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0008679 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
Elimination criteria: confirmed/suspected immunosuppressive/immunodeficient condition.
Item
Any confirmed or suspected immunosuppressive or immunodeficient condition.
boolean
C0680251 (UMLS CUI [1])
C0750484 (UMLS CUI [2,1])
C3829792 (UMLS CUI [2,2])
C0750484 (UMLS CUI [3,1])
C4048329 (UMLS CUI [3,2])
C0242114 (UMLS CUI [4,1])
C3829792 (UMLS CUI [4,2])
C0242114 (UMLS CUI [5,1])
C4048329 (UMLS CUI [5,2])
Elimination criteria: immunoglobulins/any blood derived products
Item
Administration of immunoglobulins and/or any blood derived products.
boolean
C0680251 (UMLS CUI [1])
C0021027 (UMLS CUI [2])
C0456388 (UMLS CUI [3])
Elimination criteria: use of investigational or non-registered product
Item
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s).
boolean
C0680251 (UMLS CUI [1])
C0304229 (UMLS CUI [2,1])
C0042210 (UMLS CUI [2,2])
C1444655 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Item Group
Withdrawing from study
C0422727 (UMLS CUI-1)
Item
Was the subject withdrawn from the study?
text
Withdrawal from study
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Reason for withdrawal
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Reason for withdrawal
Code List
Reason for withdrawal
CL Item
Serious adverse event (SAE)
CL Item
Non-Serious adverse event (AEX)
CL Item
Protocol violation (PTV)
CL Item
Consent withdrawal, not due to an adverse event (CWS)
CL Item
Migrated / moved from the study area (MIG)
CL Item
Lost to follow-up (LFU)
CL Item
Other (OTH)
SAE Number
Item
If SAE, please specify SAE Number
integer
C1519255 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
AE Number
Item
If AEX, please specify AE Number
integer
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Solicited AE Code
Item
If AEX, please specify solicited AE Code
integer
C0683368 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
Protocol violation
Item
If protocol violation, please specify
text
C1709750 (UMLS CUI [1])
Withdrawal, other reason
Item
If other reason for withdrawal, please specify
text
C2349954 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
Item
Who made the decision
text
C0679006 (UMLS CUI [1])
Dicision made by
Code List
Who made the decision
CL Item
Investigator  (I)
CL Item
Parents/Guardians (P)
Date of last contact
Item
Date of last contact
date
C0805839 (UMLS CUI [1])
Item
Was the subject in good condition at date of last contact
text
C0805839 (UMLS CUI [1,1])
C1142435 (UMLS CUI [1,2])
Condition at date of last contact
Code List
Was the subject in good condition at date of last contact
CL Item
No (N)
CL Item
Yes (Y)
Item Group
INVESTIGATOR'S SIGNATURE
C2346576 (UMLS CUI-1)
Investigator's signature
Item
Investigator's signature
text
C2346576 (UMLS CUI [1])
Date of signature
Item
Date of signature
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Printed Investigator's name
Item
Printed Investigator's name
text
C2826892 (UMLS CUI [1])
Volver a la parte superior de la página 

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial